US 11,939,617 B2
Functionally modified polypeptides and radiobiosynthesis
Stephen DiMagno, Chicago, IL (US)
Assigned to Ikaria Inc., Chicago, IL (US)
Filed by Ikaria Inc., Chicago, IL (US)
Filed on Dec. 2, 2021, as Appl. No. 17/540,316.
Application 17/540,316 is a division of application No. 15/695,831, filed on Sep. 5, 2017, granted, now 11,214,820.
Claims priority of provisional application 62/383,382, filed on Sep. 2, 2016.
Prior Publication US 2023/0332199 A1, Oct. 19, 2023
Int. Cl. C12P 21/02 (2006.01); C07B 59/00 (2006.01); C07C 233/51 (2006.01); C07C 327/42 (2006.01); C07C 327/44 (2006.01); C07K 14/54 (2006.01); C07K 14/545 (2006.01); C12N 9/00 (2006.01)
CPC C12P 21/02 (2013.01) [C07B 59/001 (2013.01); C07B 59/008 (2013.01); C07C 233/51 (2013.01); C07C 327/42 (2013.01); C07C 327/44 (2013.01); C07K 14/54 (2013.01); C07K 14/545 (2013.01); C12N 9/93 (2013.01); C12Y 601/01026 (2013.01); C07B 2200/05 (2013.01)] 2 Claims
 
1. A non-naturally occurring amino acid selected from the group consisting of:

OG Complex Work Unit Chemistry
 
2. A non-naturally occurring amino acid selected from the group consisting of
Nε-(4-(4-iodophenyl)butanoyl)lysine,
Nε-(4-(4-iodophenyl)butanethioyl)lysine, and
Nε-(3-(4-iodophenyl)propanoyl)lysine.